human | Q5 |
P496 | ORCID iD | 0000-0001-5313-4828 |
P1053 | ResearcherID | F-4213-2012 |
P1153 | Scopus author ID | 16069415300 |
P69 | educated at | Maimonides Medical Center | Q6735870 |
University of Alabama at Birmingham | Q1472663 | ||
P108 | employer | University of Colorado Denver | Q1468161 |
University of Alabama at Birmingham | Q1472663 | ||
P106 | occupation | researcher | Q1650915 |
Q41961043 | 3D pulmospheres serve as a personalized and predictive multicellular model for assessment of antifibrotic drugs |
Q90929540 | Author Correction: Metformin reverses established lung fibrosis in a bleomycin model |
Q37424906 | Developmental Reprogramming in Mesenchymal Stromal Cells of Human Subjects with Idiopathic Pulmonary Fibrosis. |
Q48013021 | Distal airway microbiome is associated with immunoregulatory myeloid cell responses in lung transplant recipients. |
Q36283317 | Metabolic Reprogramming Is Required for Myofibroblast Contractility and Differentiation. |
Q89393778 | Metformin reverses established lung fibrosis in a bleomycin model |
Q48261825 | Mitochondrial Dysfunction in Pulmonary Fibrosis. |
Q36549047 | Novel Mechanisms for the Antifibrotic Action of Nintedanib. |
Q98394327 | Oxidative cross-linking of fibronectin confers protease resistance and inhibits cellular migration |
Q92802221 | Remember Me? The Bone Marrow in Pulmonary Fibrosis |
Q34609734 | Restless legs syndrome in Indian patients having iron deficiency anemia in a tertiary care hospital |
Q39812240 | Restless legs syndrome in an Indian urban population |
Q35556478 | SMAD-independent down-regulation of caveolin-1 by TGF-β: effects on proliferation and survival of myofibroblasts |
Q37080510 | Targeted Therapy for Idiopathic Pulmonary Fibrosis: Where To Now? |
Q54115663 | The TAMing of the IPF Myofibroblast: One Step Closer? |
Search more.